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 التقارير املختصرة واملبوَّبة يف مقابل التقارير السردية عن نتائج خزعات
الربوستاتة يف مؤسسة رعاية صحية ثالثية
التحديات والنجاحات والتوقعات
ننامدي ابومنمي اأواره، �سارل�ص انابوبي، ريفي�ص ويل اوجولو
abstract: Objectives: Cancer pathology reports are expected to contain all information required for patient 
management and disease surveillance. Moreover, reports for patients with prostate cancer have become increasingly 
complex with the addition of more pathological details. This study aimed to compare narrative and synoptic 
prostate cancer reports for core needle biopsies received at a tertiary hospital in Nigeria in order to determine 
which form was most complete according to international standards. Methods: This study was conducted 
from January 2010 to December 2015 at the Lagos University Teaching Hospital, Lagos, Nigeria. All malignant 
prostate cancer histopathology reports received during this period were analysed for the presence of important 
clinicopathological parameters, including the numbers of cores taken and those involved by the tumour, percentage 
of tumour involvement, Gleason score and the presence of high-grade prostatic intraepithelial neoplasms 
(HGPINs) and perineural and lymphovascular invasion. Results: A total of 83 reports were reviewed, of which 27 
were in narrative and 56 in synoptic format. The documentation of clinicopathological characteristics in narrative 
reports was significantly incomplete compared to synoptic reports in recording the number of cores (33.3% versus 
96.4%), number of cores involved by the tumour (11.1% versus 94.6%), percentage of cores involved by the tumour 
(3.7% versus 100.0%) and the presence of HGPINs (7.4% versus 100.0%) and perineural (59.3% versus 98.2%) and 
lymphovascular (48.1% versus 100.0%) invasion (P <0.001 each). Conclusion: Synoptic reports of malignant 
prostate cancer biopsies received at the Lagos University Teaching Hospital were found to contain more complete 
information than narrative reports.
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امللخ�ص: الهدف: يتوقع اأن ت�ستمل تقارير باثولوجيا ال�رصطان على كل املعلومات املطلوبة لعالج املري�ص وتر�سد املر�ص. وباالإ�سافة 
لذلك غدت التقارير التي تكتب عن مر�سى �رصطان الربو�ستاتة اأكرث تعقيدا ب�سبب اإ�سافة املزيد من التفا�سيل الباثولوجية فيها. وتهدف هذه 
بة يف مقابل التقارير ال�رصدية عن نتائج خزعات اللب باالإبرة، والتي وردت مل�ست�سفى ثالثي يف  الدرا�سة ملقارنة التقارير املخت�رصة واملبَوّ
نيجرييا، وذلك لتحديد اأي نوع من تلك التقارير اأقرب للكمال بح�سب املعايري الدولية. الطريقة: اأجريت الدرا�سة بني يناير 2010 ودي�سمرب 
2015م يف م�ست�سفى جامعة الجو�ص التعليمي بنيجرييا. ومت حتليل كل التقارير الهي�ستوباثلوجية التي كتبت عن عينات �رصطان الربو�ستاتة 
اخلبيث يف تلك الفرتة، وتقييم احتوائها على املتثابتات الباثولوجية–ال�رصيرية، والتي ت�سمل اأعداد االألباب التي اأخذت، واأعداد تلك التي لها 
عالقة بال�رصطان، والن�سبة املئوية لتلك العالقة، وا�ستخدم حرز جلي�سون، ووجود اأورام بدرجة عالية يف داخل ظهارة الربو�ستاتة، ووجود 
غزو ملفاوي وعائي وغزو حميط بالع�سب. النتائج: مت حتليل 83 تقريرا، كان 27 منها تقريرا �رصديا، و56 تقريرا خمت�رصا مبوبا.  وكان 
بة فيما يتعلق  توثيق اخلوا�ص الباثولوجية–ال�رصيرية يف التقارير ال�رصدية اأقل كماال ب�سورة معنوية مقارنة مع التقارير املخت�رصة واملبَوّ
عدد االألباب )%33.3 يف مقابل%96.4(، وكان عدد االألباب التي لها عالقة بال�رصطان )%11.1 يف مقابل%94.6( وكانت الن�سبة املئوية 
لعدد االألباب التي لها عالقة بال�رصطان )%3.7 يف مقابل %100.0( ووجود اأورام بدرجة عالية يف داخل ظهارة الربو�ستاتة )%7.4 يف 
P >0.001( )100.0% مقابل %100.0(، ووجود غزو حميط بالع�سب )%59.3 يف مقابل %98.2( وغزو ملفاوي وعائي )%48.1 يف مقابل 
تلقاها  التي  خبيث  ب�رصطان  امل�سابة  الربو�ستاتة  خزعات  نتائج  عن  بة  واملبَوّ املخت�رصة  التقارير  اأن  وجدنا  اخلال�صة:  حالة(.  كل  يف 
م�ست�سفى الجو�ص التعليمي حتتوي على معلومات اأكرث �سموال من تلك التي وردت يف التقارير ال�رصدية.
الكلمات املفتاحية: الباثولوجيا؛ خزعة؛ �رصطان الربو�ستاتة؛ اأورام بداخل ظهارة الربو�ستاتة؛ نيجرييا. 
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Advances in Knowledge 
- The findings of this study confirm the significant advantage of synoptic over narrative report formats in ensuring the completeness of 
histopathology reports for prostate cancer biopsies.
- Recommendations are suggested to facilitate the adoption of the synoptic reporting template at other healthcare institutions.
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Application to Patient Care
- Complete prostate cancer biopsy reports should document the various clinicopathological parameters required for prognostication 
purposes. As such, the usefulness of certain reporting styles over others in highlighting significant parameters may contribute to 
management decisions, thereby improving the quality of patient care.
In nigeria, prostate cancer is the most common form of male cancer and the highest cause of cancer-related deaths among men.1 Prostate 
cancer management requires a multidisciplinary 
approach which brings together both clinicians and 
pathologists. Currently, histological assessments remain 
the gold standard for making a diagnosis of prostate 
cancer.2 Therefore, the precise and thorough docu-
mentation of histological findings is important to 
ensure an accurate diagnosis, determine patient prog-
nosis and inform patient management decisions.3 
The need for increased details and standardisation 
in histology reports has led to the development of 
various checklists; accordingly, both the College of 
American Pathologists (CAP) and the Royal College 
of Pathologists (RCPath) have developed specific 
formats and protocols for histopathology reporting.3,4 
For prostate cancer, the necessary information in 
a pathology report includes the presence and type of 
cancer, Gleason score, neural involvement, lympho-
vascular invasion, periprostatic fat and seminal vesicle 
involvement (where applicable) and the presence 
of high-grade prostatic intraepithelial neoplasms 
(HGPINs). In addition, the RCPath documentation 
also includes a microscopic count of the number 
of cores and the percentage of cores involved by the 
tumour.4 However, these details depend on whether 
the biopsy sample was taken via core needle or radical 
prostatectomy.
At the Lagos University Teaching Hospital, 
a tertiary healthcare centre in Lagos, Nigeria, the 
synoptic form of reporting prostate cancer specimens 
was adopted in 2015, with a gradual transition from 
the former narrative style between 2015 and 2016. This 
study aimed to compare narrative versus synoptic forms 
of prostate cancer histopathology reports received at 
the Lagos University Teaching Hospital according to 
established international standards. In addition, the 
benefits of synoptic reporting are discussed as well as 
solutions to offset possible challenges that may arise 
during the transition to a synoptic style of reporting. 
Methods
This study was conducted from January 2010 to 
December 2015 at the Lagos University Teaching 
Hospital. All reports of malignant core needle 
prostate cancer biopsy specimens received during this 
period were reviewed. As per the CAP and RCPath 
protocols for reporting prostate cancer, inclusion of 
the following parameters in the reports was noted: 
microscopic count of the number of cores, nature of 
the tumour, number of cores involved, total percentage 
of cores involved by the tumour, Gleason score and 
the presence of high-grade prostatic intraepithelial 
neoplasms (HGPINs) and lymphovascular and neural 
invasion.3,4 
Data were analysed using descriptive statistics. 
Statistical significance was determined using Fisher’s 
exact test with the level of significance set at P <0.005. 
Ethical approval for the study was granted by the 
Health Research and Ethics Committee of the Lagos 
University Teaching Hospital. The names of the 
patients were blinded and only biopsy numbers were 
used for the purposes of identification.
Results
A total of 83 malignant prostate biopsies were received 
during the study period. Of these, 27 (32.5%) were 
reported narratively and 56 (67.5%) were reported 
synoptically. Synoptic reports documented the 
number of cores in 96.4% of cases, while narrative 
reports contained this information in only 33.3% 
of cases. The number of cores involved by the 
tumour and percentage of core involvement was 
described in 94.6% and 100.0% of synoptic reports, 
respectively, and 11.1% and 3.7% of narrative reports, 
Figure 1: Comparison of parameters documented in 
synoptic versus narrative reports of malignant prostate 
cancer biopsies received at the Lagos University 
Teaching Hospital, Lagos, Nigeria (N = 83).
HGPIN = high-grade prostatic intraepithelial neoplasia. 
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respectively. Gleason scores were recorded in all 
reports, regardless of format. Only 7.4% of narrative 
reports noted the presence of HGPINs as compared 
to 100.0% of synoptic reports. Finally, perineural and 
lymphovascular invasion was documented in 98.2% 
and 100.0% of synoptic reports, respectively, and 
59.3% and 48.1% of narrative reports, respectively 
[Figure 1]. Apart from Gleason score, documentation 
of all clinicopathological parameters was significantly 
greater in synoptic compared to narrative reports 
(P <0.001 each) [Table 1]. 
Discussion
In prostate cancer biopsy reports, recording the 
number of cores is important as this count is 
subsequently correlated with the number of biopsies 
taken, processed and present on the histology slide; this 
approach serves as an internal quality control measure 
to ensure that all tissues submitted for biopsy are duly 
processed. Moreover, the number of cores involved by 
the tumour and the total percentage of cores involved 
are major determinants of prognosis as they are both 
indicative of the overall size of the tumour.5–7 As per 
the CAP protocols, it is imperative that the number 
of positive cores out of the total number of cores are 
invariably reported for needle core biopsy specimens, 
except in cases where a precise count is impossible 
due to fragmentation.5 Freedland et al. reported that 
the percentage of the area of biopsy tissue with 
cancer was the strongest predictor of biochemical 
recurrence, seminal vesicle invasion and non-organ-
confined disease.6 In addition, Brimo et al. reported 
that the portion of cores involved by the tumour, 
total percentage of tumour involvement and both the 
total and greatest tumour lengths in millimetres were 
the variables most closely linked with pathological 
stage and treatment failure.7 Critically, there was a 
vast difference between the documentation of these 
parameters in the synoptic and narrative reports 
reviewed in the current study.
Another remarkable discrepancy between 
synoptic and narrative reports in the present study 
was in the documentation of HGPINs. According to 
the CAP, the documentation of HGPINs in a prostate 
cancer specimen is optional.5 However, this factor may 
be important in benign cases in which widespread 
HGPINs could signify the potential development 
of an adenocarcinoma and therefore warrant close 
follow-up; for example, Netto et al. found that 40 out 
of 41 patients with widespread HGPINs developed 
prostate cancer within two years of diagnosis.8 The 
presence of perineural invasion is similarly important 
in determining treatment strategy. After a two-year 
follow up of patients treated with external beam 
radiotherapy, Yu et al. demonstrated that perineural 
invasion was more prevalent in higher-risk groups and 
was associated with an increased risk of biochemical 
recurrence.9 However, this factor did not result in 
significantly different long-term PSA recurrence 
rates in a study by O’Malley et al., nor was there 
any significant difference in final Gleason scores or 
pathological staging among cohorts.10
In contrast, Vargas et al. found that perineural 
invasion was a likely predictor of extraprostatic 
extension in prostatectomy samples.11 In the current 
study, Gleason score was the only factor which was 
emphasised in both synoptic and narrative reports. 
This finding might be connected with longstanding 
and irrefutable evidence indicating that Gleason 
Table 1: Parameters documented in narrative versus synoptic reports of malignant prostate cancer biopsies received 
at the Lagos University Teaching Hospital, Lagos, Nigeria (N = 83)
Parameter n (%) P value*




Documented Not documented Documented Not documented
Number of cores† 9 (33.3) 18 (66.7) 54 (96.4) 2 (3.6) <0.001
Number of cores involved by tumour 3 (11.1) 24 (88.9) 53 (94.6) 3 (5.4) <0.001
Percentage of cores involved 1 (3.7) 26 (96.3) 56 (100.0) 0 (0.0) <0.001
Gleason score 27 (100) 0 (0.0) 56 (100.0) 0 (0.0) >0.999
Presence of high-grade PIN 2 (7.4) 25 (92.6) 56 (100.0) 0 (0.0) <0.001
Perineural invasion 16 (59.3) 11 (40.7) 55 (98.2) 1 (1.8) <0.001
Lymphovascular invasion 13 (48.1) 14 (51.9) 56 (100.0) 0 (0.0) <0.001
PIN = prostatic intraepithelial neoplasia.
*Using Fisher’s exact test. †As observed microscopically.
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score is a major determinant of prognosis in prostate 
cancer.12 
In general, there are numerous benefits to 
synoptic in comparison to narrative biopsy reporting. 
With narrative reports, clinicians must comb 
through a large amount of macroscopic, microscopic, 
diagnostic and other information in order to 
unearth the essential knowledge required for clinical 
decision-making.3 In contrast, the uniform template 
of synoptic reports facilitates research and decision-
making by highlighting significant diagnostic and 
prognostic findings; this also lessens the likelihood 
of misinterpreting results or making clinical errors.13 
Moreover, the reporting of results in a synoptic 
format is useful for tumour registries, government 
agencies, health planners and researchers by ensuring 
the uniformity of documentation received from 
various sources.13 Previous studies evaluating various 
formats for reporting head and neck, colorectal 
and breast cancer specimens have concluded that 
synoptic reporting is associated with significantly 
higher rates of information completeness.14–16 Overall, 
the implementation of standard synoptic reporting 
criteria will lead to the production of uniform high-
quality prostate cancer biopsy reports.
Nevertheless, the transition from narrative to 
synoptic reporting standards can be challenging. At 
the Lagos University Teaching Hospital, ultrasound-
guided prostate biopsies are not routinely received 
and sometimes all biopsies taken from one patient 
are transported in a single container due to financial 
constraints. Such practices make synoptic reports 
less valuable as the cores involved cannot be traced 
to one particular zone of the prostate. Suggestions 
that may be helpful to ensure compliance with CAP 
standards include financial incentives to participating 
institutions for producing a complete pathology report 
and grading the performance of an individual centre 
with regards to their adoption of the CAP checklist.13 
In particular, a constructive feedback loop should 
be established between surgeons and pathologists, 
of which the latter should be encouraged to comply 
with synoptic reporting methods and train resident 
doctors in their use. The involvement of surgeons 
during the transition to a synoptic checklist is one 
factor that cannot be overemphasised, particularly 
as they are the final recipient of the biopsy report in 
most cases.13 These strategies were implemented at 
the Lagos University Teaching Hospital and, although 
constraints still exist in terms of surgical equipment 
and patient costs, the institution has witnessed a 
gradual adoption of the synoptic style of reporting.
Conclusion
Synoptic reporting of malignant prostate cancer 
biopsies received at the Lagos University Teaching 
Hospital produced significantly more complete 
reports than those documented in a narrative format. 
The adoption of synoptic reporting standards is highly 
recommended to ensure the production of complete 
and uniform biopsy reports.
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